(3-266) Dysregulated Biological Processes in Pancreatic Ductal Adenocarcinoma Cancer (PDAC) Patients Treated with FOLFIRINOX as Standard Chemotherapy

Monday, December 5, 2022

12:00 PM – 1:00 PM

Location: Bayside A, Level 1

Category: Evaluative Study
Topic: Oncology/Hematology

Co-Author(s): Kawther Abdilleh, George Acquaah-Mensah

Primary Author(s)

Hao Huynh
Student
Massachusetts College of Pharmacy and Health Sciences, Massachusetts